Clinical Trial

Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention

Study acronym: BHB-CRC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to assess the feasibility of beta-hydroxybutyrate (BHB) supplementation in individuals who are undergoing a standard-of-care colonoscopy or flexible sigmoidoscopy.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-30 -> 2027-06-30 2026-08-13
minor Completion pushed: 2026-06-30 -> 2027-06-30 2026-08-13
Trial Details
NCT Number NCT05338307
Lead Sponsor Abramson Cancer Center at Penn Medicine
Conditions Colorectal Cancer
Enrollment 20 participants
Start Date 2022-05-13
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-12